Transfer of Care Agreements

Colesevelam for bile acid malabsorption following cancer treatment

Colesevelam for bile acid malabsorption for non-cancer indications in adults

DOAC: For stroke prevention in non-valvular atrial fibrillation

DOAC: For venous thromboembolism

DOAC: Rivaroxaban for acute coronary syndrome

Croydon, Merton, Sutton and Wandsworth Only:

LMWH for the treatment of deep vein thrombosis or pulmonary embolism associated with cancer in palliative care patients discharged from oncology service

Mesalazine for the treatment of inflammatory bowel disease

Please note the above document is currently under review. It contains reference to azathioprine, mercaptopurine, methotrexate and sulfasalazine which have been updated. Please see updated NHS SWL shared care (adapted from national shared care) for:

Midodrine

This transfer of care document is for use for the transfer of prescribing responsibility for the following indications:

  • Inappropriate sinus tachycardia (IST)
  • Postural orthostatic tachycardia syndrome (POTS)
  • Severe orthostatic hypotension due to autonomic dysfunction